M.E. Morgans

747 total citations
14 papers, 413 citations indexed

About

M.E. Morgans is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Health, Toxicology and Mutagenesis. According to data from OpenAlex, M.E. Morgans has authored 14 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 2 papers in Health, Toxicology and Mutagenesis. Recurrent topics in M.E. Morgans's work include Thyroid Disorders and Treatments (4 papers), Sympathectomy and Hyperhidrosis Treatments (2 papers) and Head and Neck Anomalies (2 papers). M.E. Morgans is often cited by papers focused on Thyroid Disorders and Treatments (4 papers), Sympathectomy and Hyperhidrosis Treatments (2 papers) and Head and Neck Anomalies (2 papers). M.E. Morgans collaborates with scholars based in United Kingdom and Iceland. M.E. Morgans's co-authors include Wilfred Trotter, G. R. Fraser, C. E. Dent, B. D. Thompson, John C. Kermode, C. J. Edmonds, J E Lennard‐Jones, C G Clark, P M Smith and A G Spencer and has published in prestigious journals such as The Lancet, Gut and Journal of Endocrinology.

In The Last Decade

M.E. Morgans

13 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.E. Morgans United Kingdom 10 163 119 82 78 74 14 413
Nadia Cerutti Italy 12 160 1.0× 137 1.2× 127 1.5× 118 1.5× 54 0.7× 23 425
Ruben N. Eppinga Netherlands 8 36 0.2× 46 0.4× 38 0.5× 85 1.1× 7 0.1× 9 438
Swathi Appachi United States 10 29 0.2× 65 0.5× 18 0.2× 39 0.5× 39 0.5× 23 329
Dong Kuck Lee South Korea 7 21 0.1× 58 0.5× 100 1.2× 10 0.1× 11 0.1× 18 302
Jan Van Schoor Belgium 11 6 0.0× 66 0.6× 7 0.1× 86 1.1× 13 0.2× 19 704
Robert J. Strobos United States 10 101 0.6× 6 0.1× 9 0.1× 22 0.3× 9 0.1× 15 392
Wouter Vandamme Belgium 9 9 0.1× 26 0.2× 22 0.3× 234 3.0× 6 0.1× 11 462
J.L. Berry United Kingdom 11 52 0.3× 17 0.1× 4 0.0× 162 2.1× 2 0.0× 31 461
F. Carpino Italy 10 18 0.1× 10 0.1× 22 0.3× 45 0.6× 2 0.0× 35 382
Ahmet Çorakçı Türkiye 11 226 1.4× 10 0.1× 24 0.3× 44 0.6× 1 0.0× 22 422

Countries citing papers authored by M.E. Morgans

Since Specialization
Citations

This map shows the geographic impact of M.E. Morgans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.E. Morgans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.E. Morgans more than expected).

Fields of papers citing papers by M.E. Morgans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.E. Morgans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.E. Morgans. The network helps show where M.E. Morgans may publish in the future.

Co-authorship network of co-authors of M.E. Morgans

This figure shows the co-authorship network connecting the top 25 collaborators of M.E. Morgans. A scholar is included among the top collaborators of M.E. Morgans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.E. Morgans. M.E. Morgans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kermode, John C., C. J. Edmonds, & M.E. Morgans. (1984). Receptors for thyroid-stimulating hormone in normal and pathological human thyroid tissues. Journal of Endocrinology. 102(3). 369–374. 8 indexed citations
2.
Morgans, M.E., et al.. (1978). SPORADIC NON‐TOXIC GOITRE: AN INVESTIGATION OF THE HYPOTHALAMIC–PITUITARY–THYROID AXIS. Clinical Endocrinology. 8(2). 101–108. 13 indexed citations
3.
Smith, P M, et al.. (1975). Lipodystrophy, pancreatitis, and eosinophilia.. Gut. 16(3). 230–234. 14 indexed citations
4.
Morgans, M.E. & Wilfred Trotter. (1960). Potassium Perchlorate in Thyrotoxicosis. BMJ. 2(5205). 1086–1087. 14 indexed citations
5.
Fraser, G. R., M.E. Morgans, & Wilfred Trotter. (1960). THE SYNDROME OF SPORADIC GOITRE AND CONGENITAL DEAFNESS. QJM. 29. 279–95. 80 indexed citations
6.
Morgans, M.E. & Wilfred Trotter. (1959). IODOPYRINE AS A CAUSE OF GOITRE. The Lancet. 274(7099). 374–375. 16 indexed citations
7.
Morgans, M.E. & Wilfred Trotter. (1958). ASSOCIATION OF CONGENITAL DEAFNESS WITH GOITRE THE NATURE OF THE THYROID DEFECT. The Lancet. 271(7021). 607–609. 122 indexed citations
8.
Morgans, M.E. & Wilfred Trotter. (1957). DEFECTIVE ORGANIC BINDING OF IODINE BY THE THYROID IN HASHIMOTO'S THYROIDITIS. The Lancet. 269(6968). 553–555. 59 indexed citations
9.
Spencer, A G & M.E. Morgans. (1956). LENTE INSULIN. The Lancet. 268(6951). 1013–1017. 2 indexed citations
10.
Dent, C. E., et al.. (1955). INSENSITIVITY TO VITAMIN D DEVELOPING DURING THE TREATMENT OF POSTOPERATIVE TETANY. The Lancet. 266(6892). 687–690. 21 indexed citations
11.
Morgans, M.E. & Wilfred Trotter. (1954). TREATMENT OF THYROTOXICOSIS WITH POTASSIUM PERCHLORATE. The Lancet. 263(6815). 749–751. 22 indexed citations
12.
Morgans, M.E. & Wilfred Trotter. (1954). TREATMENT OF THYROTOXICOSIS WITH POTASSIUM PERCHLORATE. The Lancet. 263(6817). 883–883.
13.
Morgans, M.E. & Wilfred Trotter. (1953). TWO CASES OF MYXŒDEMA ATTRIBUTED TO IODIDE ADMINISTRATION. The Lancet. 262(6800). 1335–1337. 38 indexed citations
14.
Morgans, M.E., et al.. (1952). Conduct of Pregnancy Complicated by Diabetes Mellitus. BMJ. 1(4767). 1058–1060. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nadia Cerutti Breakdown of academic impact, for papers by Ruben N. Eppinga Breakdown of academic impact, for papers by Swathi Appachi Breakdown of academic impact, for papers by Dong Kuck Lee Breakdown of academic impact, for papers by Jan Van Schoor Breakdown of academic impact, for papers by Robert J. Strobos Breakdown of academic impact, for papers by Wouter Vandamme Breakdown of academic impact, for papers by J.L. Berry Breakdown of academic impact, for papers by F. Carpino Breakdown of academic impact, for papers by Ahmet Çorakçı
Rankless by CCL
2026